Literature DB >> 10431211

VIP and PACAP: very important in pain?

T Dickinson1, S M Fleetwood-Walker.   

Abstract

Neuropathic pain arising from direct trauma to, or compression injury of, peripheral nerves is a common clinical problem. It is characterized by the development of abnormal pain states (spontaneous pain, hyperalgesia, allodynia), which can persist long after the initial injury has resolved. The underlying mechanisms are poorly understood and, as a consequence, treatment is often unsatisfactory. Some of the main contributing factors are thought to be the morphological and phenotypic changes that occur centrally, including alterations in the expression of neurotransmitters and their associated receptors, both in the dorsal root ganglia and in the spinal dorsal horn. This article focuses on the functional role of the two structurally related peptides VIP and PACAP within the spinal cord, and their possible contribution to the altered transmission of sensory information in neuropathic conditions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10431211     DOI: 10.1016/s0165-6147(99)01340-1

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  24 in total

1.  Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP.

Authors:  Henrik Winther Schytz; Helle Holst; Lars Arendt-Nielsen; Jes Olesen; Messoud Ashina
Journal:  J Headache Pain       Date:  2010-05-09       Impact factor: 7.277

2.  Mechanisms of VIP-induced inhibition of the lymphatic vessel pump.

Authors:  Pierre-Yves von der Weid; Sonia Rehal; Peter Dyrda; Stewart Lee; Ryan Mathias; Mozibur Rahman; Simon Roizes; Mohammad S Imtiaz
Journal:  J Physiol       Date:  2012-03-25       Impact factor: 5.182

3.  Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1.

Authors:  Michael Costigan; Inna Belfer; Robert S Griffin; Feng Dai; Lee B Barrett; Giovanni Coppola; Tianxia Wu; Carly Kiselycznyk; Minakshi Poddar; Yan Lu; Luda Diatchenko; Shad Smith; Enrique J Cobos; Dmitri Zaykin; Andrew Allchorne; Edith Gershon; Jessica Livneh; Pei-Hong Shen; Lone Nikolajsen; Jaro Karppinen; Minna Männikkö; Anthi Kelempisioti; David Goldman; William Maixner; Daniel H Geschwind; Mitchell B Max; Ze'ev Seltzer; Clifford J Woolf
Journal:  Brain       Date:  2010-08-18       Impact factor: 13.501

4.  Regulation of spinal dynorphin 1-17 release by endogenous pituitary adenylyl cyclase-activating polypeptide in the male rat: relevance of excitation via disinhibition.

Authors:  Nai-Jiang Liu; Stephen A Schnell; Stefan Schulz; Martin W Wessendorf; Alan R Gintzler
Journal:  J Pharmacol Exp Ther       Date:  2010-10-25       Impact factor: 4.030

Review 5.  In search of analgesia: emerging roles of GPCRs in pain.

Authors:  Laura S Stone; Derek C Molliver
Journal:  Mol Interv       Date:  2009-10

Review 6.  The PACAP receptor: a novel target for migraine treatment.

Authors:  Henrik W Schytz; Jes Olesen; Messoud Ashina
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

7.  Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.

Authors:  W K Kim; Y Kan; D Ganea; R P Hart; I Gozes; G M Jonakait
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

8.  Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RS.

Authors:  Chaohong Sun; Danying Song; Rachel A Davis-Taber; Leo W Barrett; Victoria E Scott; Paul L Richardson; Ana Pereda-Lopez; Marie E Uchic; Larry R Solomon; Marc R Lake; Karl A Walter; Philip J Hajduk; Edward T Olejniczak
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

9.  Heterogeneity of neuronal and smooth muscle receptors involved in the VIP- and PACAP-induced relaxations of the pig intravesical ureter.

Authors:  Medardo Hernández; María Victoria Barahona; Paz Recio; Luis Rivera; Sara Benedito; Ana Cristina Martínez; Albino García-Sacristán; Luis M Orensanz; Dolores Prieto
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

10.  Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents.

Authors:  Lionel Fizanne; Dominique Sigaudo-Roussel; Jean Louis Saumet; Bérengère Fromy
Journal:  J Physiol       Date:  2003-10-24       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.